| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 156.19M | 142.44M | 147.33M | 52.10M | 101.10M |
| Gross Profit | 121.85M | 83.50M | 92.46M | 23.17M | 84.93M |
| EBITDA | 103.11M | 74.74M | 84.11M | 16.50M | 87.28M |
| Net Income | 34.51M | 73.65M | 83.84M | 15.54M | 83.63M |
Balance Sheet | |||||
| Total Assets | 1.62T | 1.66B | 1.63B | 1.30B | 1.32B |
| Cash, Cash Equivalents and Short-Term Investments | 31.50B | 10.13M | 7.78M | 6.40M | 10.07M |
| Total Debt | 873.76M | 875.84M | 844.78M | 654.46M | 631.04M |
| Total Liabilities | 916.10B | 915.64M | 884.78M | 690.34M | 665.52M |
| Stockholders Equity | 706.04B | 740.64M | 742.59M | 612.54M | 652.28M |
Cash Flow | |||||
| Free Cash Flow | 74.72M | 82.75M | 61.81M | 58.38M | 28.45M |
| Operating Cash Flow | 74.72M | 82.75M | 61.81M | 58.38M | 28.45M |
| Investing Cash Flow | 27.95M | -23.85M | 30.48M | -30.43M | -186.11M |
| Financing Cash Flow | -82.54M | -43.47M | -84.99M | -34.41M | 166.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $402.52M | 3.44 | 3.34% | 15.77% | -11.01% | -65.56% | |
61 Neutral | $536.80M | 2.10 | 24.70% | 11.02% | -45.46% | 134.73% | |
59 Neutral | $404.64M | 19.71 | 7.50% | 9.31% | 41.12% | -40.68% | |
59 Neutral | $314.73M | 10.64 | 5.42% | 16.61% | -3.09% | 200.66% | |
58 Neutral | $475.20M | 15.33 | 0.02% | 13.20% | -20.18% | -61.90% | |
53 Neutral | $320.46M | -5.23 | -12.44% | 21.13% | -91.81% | 78.46% |
Crescent Capital BDC issued $67.5 million of Tranche A senior unsecured notes due February 13, 2029 and $67.5 million of Tranche B senior unsecured notes due February 13, 2031 on February 13, 2026, carrying fixed coupon rates of 5.87% and 6.20%, respectively. The company also plans to issue $50 million of Tranche C senior unsecured notes due May 22, 2029 on May 22, 2026, subject to customary closing conditions, further diversifying its long-term funding.
In conjunction with the February 13, 2026 issuances, Crescent Capital BDC entered into interest rate swaps that convert the fixed-rate obligations on the Tranche A and Tranche B notes into floating-rate exposures based on three-month term SOFR plus respective spreads of 2.5325% and 2.8050%. These swaps, which match the maturities of the underlying notes, are designed to manage the company’s interest rate risk profile and align its liabilities more closely with floating-rate assets.
The most recent analyst rating on (CCAP) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on Crescent Capital BDC stock, see the CCAP Stock Forecast page.